TNYA(Tenaya Therapeutics, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-11-17 | Ali Faraz | Chief Executive Officer | 公开市场卖出 | 3,499 | $0.32 |
| 2026-11-17 | Tingley Whittemore | Chief Medical Officer | 公开市场卖出 | 3,223 | $0.32 |
| 2026-08-17 | Ali Faraz | Chief Executive Officer | 公开市场卖出 | 7,406 | $0.71 |
| 2026-08-17 | Ali Faraz | Chief Executive Officer | 公开市场卖出 | 5,020 | $0.71 |
| 2026-08-17 | Ali Faraz | Chief Executive Officer | 公开市场卖出 | 3,969 | $0.71 |
| 2026-08-17 | Ali Faraz | Chief Executive Officer | 公开市场卖出 | 5,837 | $0.71 |
| 2026-08-17 | Tingley Whittemore | Chief Medical Officer | 公开市场卖出 | 2,279 | $0.71 |
| 2026-08-17 | Tingley Whittemore | Chief Medical Officer | 公开市场卖出 | 1,871 | $0.71 |
| 2026-08-17 | Tingley Whittemore | Chief Medical Officer | 公开市场卖出 | 1,637 | $0.71 |
| 2026-08-17 | Tingley Whittemore | Chief Medical Officer | 公开市场卖出 | 1,637 | $0.71 |
| 2026-05-18 | Ali Faraz | Chief Executive Officer | 公开市场卖出 | 3,390 | $0.79 |
| 2026-05-18 | Tingley Whittemore | Chief Medical Officer | 公开市场卖出 | 3,121 | $0.79 |
| 2026-05-18 | Higa Tomohiro | SVP, Finance | 公开市场卖出 | 1,485 | $0.79 |
| 2026-02-25 | COLUMN GROUP III GP, LP | 10% 股东 | 公开市场卖出 | 1,862,545 | $0.56 |
| 2026-02-25 | COLUMN GROUP III GP, LP | 10% 股东 | 公开市场卖出 | 1,649,281 | $0.56 |
| 2026-02-24 | COLUMN GROUP III GP, LP | 10% 股东 | 公开市场卖出 | 349,212 | $0.62 |
| 2026-02-24 | COLUMN GROUP III GP, LP | 10% 股东 | 公开市场卖出 | 309,228 | $0.62 |
| 2026-02-23 | COLUMN GROUP III GP, LP | 10% 股东 | 公开市场卖出 | 162,291 | $0.60 |
| 2026-02-23 | COLUMN GROUP III GP, LP | 10% 股东 | 公开市场卖出 | 143,709 | $0.60 |
| 2026-02-20 | COLUMN GROUP III GP, LP | 10% 股东 | 公开市场卖出 | 277,769 | $0.61 |